These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 569696)

  • 1. Characteristics of functional tolerance during barbiturate physical dependency production.
    Okamoto M; Boisse NR; Rosenberg HC; Rosen R
    J Pharmacol Exp Ther; 1978 Dec; 207(3):906-15. PubMed ID: 569696
    [No Abstract]   [Full Text] [Related]  

  • 2. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical dependence to barbital compared to pentobarbital. I. "Chronically equivalent" dosing method.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):497-506. PubMed ID: 564950
    [No Abstract]   [Full Text] [Related]  

  • 4. Barbiturate tolerance and physical dependence: contribution of pharmacological factors.
    Okamoto M
    NIDA Res Monogr; 1984; 54():333-47. PubMed ID: 6442760
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M; Hinman DJ; Aaronson LM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):514-25. PubMed ID: 564952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):526-40. PubMed ID: 564953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic minipumps for administration of barbital to mice: demonstration of functional tolerance and physical dependence.
    Siew C; Goldstein DB
    J Pharmacol Exp Ther; 1978 Mar; 204(3):541-6. PubMed ID: 564954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration.
    Stolman S; Loh HH
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical dependence produced by long duration, low dose chronic barbital treatment.
    Okamoto M; Hinman DJ
    Subst Alcohol Actions Misuse; 1984; 5(2):97-103. PubMed ID: 6540898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic delta 9-tetrahydrocannabinol administration on schedule-controlled behavior of pigeons: cross-tolerance to pentobarbital and barbital.
    Chait LD; Brocco MJ; McMillan DE
    Psychopharmacology (Berl); 1981; 75(1):1-4. PubMed ID: 6272342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of cross-tolerance between barbiturates and phencyclidine.
    Flint BA; Ho IK
    Subst Alcohol Actions Misuse; 1980; 1(3):287-93. PubMed ID: 7347920
    [No Abstract]   [Full Text] [Related]  

  • 13. A model for the rapid induction of barbiturate tolerance.
    Mann PA; Isom GE
    Proc West Pharmacol Soc; 1978; 21():387-90. PubMed ID: 693521
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is liver microsomal enzyme induction the cause of tolerance to barbiturates?].
    Sergeev PV; Vedernikova NN; Maĭskiĭ AI
    Farmakol Toksikol; 1976; 39(2):208-12. PubMed ID: 1278355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dosing frequency on the development of physical dependence and tolerance to pentobarbital.
    Okamoto M; Rao S; Walewski JL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1004-8. PubMed ID: 3746655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional distribution of barbital in the brain of mice during the development of tolerance and physical dependence.
    Lin SC; Sutherland VC
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):215-31. PubMed ID: 562525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance characteristics produced during the maximally tolerable chronic pentobarbital dosing in the cat.
    Okamoto M; Rosenberg HC; Boisse NR
    J Pharmacol Exp Ther; 1975 Mar; 192(3):555-69. PubMed ID: 1120956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of tolerance to and physical dependence on barbiturates in rhesus monkeys.
    Yanagita T; Takahashi S
    J Pharmacol Exp Ther; 1970 Mar; 172(1):163-9. PubMed ID: 4984668
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to ethanol and cross-tolerance to pentobarbital and barbital.
    Gougos A; Khanna JM; Lê AD; Kalant H
    Pharmacol Biochem Behav; 1986 Apr; 24(4):801-7. PubMed ID: 3714775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.